1. Association between PPARγ, PPARGC1A, and PPARGC1B genetic variants and susceptibility of gastric cancer in an Eastern Chinese population
   Boyang Chen et al, 2022, BMC Medical Genomics CrossRef
2. Peroxisome proliferator activated receptors at the crossroad of obesity, diabetes, and pancreatic cancer
   Simone Polvani, 2016, World Journal of Gastroenterology CrossRef
3. Variation of PPARG Expression in Chemotherapy-Sensitive Patients of Hypopharyngeal Squamous Cell Carcinoma
   Meng Lian et al, 2021, PPAR Research CrossRef
4. Inhibition of Prostaglandin Reductase 2, a Putative Oncogene Overexpressed in Human Pancreatic Adenocarcinoma, Induces Oxidative Stress-Mediated Cell Death Involving xCT and CTH Gene Expressions through 15-Keto-PGE2
   Emily Yun-Chia Chang et al, 2016, PLOS ONE CrossRef
5. Peroxisome Proliferator-Activated Receptors and the Hallmarks of Cancer
   Nicole Wagner et al, 2022, Cells CrossRef
6. Pparg may Promote Chemosensitivity of Hypopharyngeal Squamous Cell Carcinoma
   Meng Lian et al, 2020, PPAR Research CrossRef
7. PPARγ Agonists in Combination Cancer Therapies
   Piotr Mrowka et al, 2020, Current Cancer Drug Targets CrossRef